What's in Jiangsu Aosaikang Pharmaceutical Co., Ltd.'s pipeline?

Jiangsu Aosaikang Pharmaceutical Co., Ltd. has 6 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 0 in Phase 2, 4 in Phase 1.

Which companies overlap with Jiangsu Aosaikang Pharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: Dong-A ST Co., Ltd., Elion Therapeutics, Inc., Hadassah Medical Organization, Hatem AbuHashim, Janssen Pharmaceutical K.K..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/jiangsu-aosaikang-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Jiangsu Aosaikang Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jiangsu Aosaikang Pharmaceutical Co., Ltd. pipeline: 0 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 0 Phase 2 4 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
ASKC202+ Limertinib	ASKC202+ Limertinib	phase 3	Bispecific antibody + third-generation EGFR tyrosine kinase inhibitor combination	EGFR (epidermal growth factor receptor) and c-MET (mesenchymal-epithelial transition factor)	Oncology
ASK120067	ASK120067	phase 3

Therapeutic area mix

Infectious Disease · 1
Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Dong-A ST Co., Ltd. · 1 shared drug class
Elion Therapeutics, Inc. · 1 shared drug class
Hadassah Medical Organization · 1 shared drug class
Hatem AbuHashim · 1 shared drug class
Janssen Pharmaceutical K.K. · 1 shared drug class
Military Hospital of Tunis · 1 shared drug class
Mycovia Pharmaceuticals Inc. · 1 shared drug class
Nuvation Bio Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Jiangsu Aosaikang Pharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Jiangsu Aosaikang Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/jiangsu-aosaikang-pharmaceutical-co-ltd. Accessed 2026-05-17.